Real-world Data Reveal Long Drug Survival for Guselkumab in Patients with Plaque Psoriasis

被引：4
|
作者：
Van Muijen, Marloes E. [1 ,2 ]
Thomas, Sarah E. [1 ,2 ]
Vellinga, Douwe [3 ]
Bouwman, Silke [4 ]
Van Doorn, Martijn B. A. [5 ]
Politiek, Klaziena [6 ]
Otero, Marisol E. [1 ,2 ]
Van den Reek, Juul M. P. A. [1 ,2 ]
De Jong, Elke M. G. J. [1 ,2 ,7 ]
机构：
[1] Radboud Univ Nijmegen, Dept Dermatol, Med Ctr, Geert Grootepl Zuid 10,Postbus 9101, NL-6525 GA Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Med Ctr, Geert Grootepl Zuid 10,Postbus 9101, NL-6525 GA Nijmegen, Netherlands
[3] Alrijne Ziekenhuis, Dept Dermatol, Leiderdorp, Netherlands
[4] Univ Med Ctr Groningen, Groningen, Netherlands
[5] Erasmus MC, Rotterdam, Netherlands
[6] Med Ctr Leeuwarden, Leeuwarden, Netherlands
[7] Radboud Univ Nijmegen, Nijmegen, Netherlands
来源：
ACTA DERMATO-VENEREOLOGICA | 2022年 / 102卷
关键词：
D O I：
10.2340/actadv.v102.685
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Drug Survival Outcomes Associated with the Real-World Use of Ixekizumab, Secukinumab, Guselkumab, and Adalimumab for the Treatment of Plaque Psoriasis in China: A 52-Week Single-Center Retrospective Study
    Li, Ying
    Lu, Jia-Jing
    Zhong, Xiao-Yuan
    Yu, Ying-Yuan
    Yu, Ning
    Wang, Yu
    Yi, Xue-Mei
    Ding, Yang-Feng
    Shi, Yu-Ling
    [J]. CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2022, 15 : 2245 - 2252
  • [42] Survival of guselkumab therapy in moderate to severe plaque psoriasis at 52 weeks in a real-world clinical setting: observational, retrospective, multi-centre study by the Spanish Psoriasis Group
    del Alcazar, Elena
    Lopez-Ferrer, Anna
    Martinez-Domenech, Alvaro
    Julia, Marc
    Ruiz-Villaverde, Ricardo
    Rodriguez Fernandez-Freire, Lourdes
    Notario, Jaime
    Llamas-Velasco, Mar
    Ferran, Marta
    Carrascosa, Jose Manuel
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (06) : 2878 - 2880
  • [43] Real-World Insight on Apremilast Therapy in Patients with Plaque Psoriasis: Indian Experience
    De, Abhishek
    Das, Sudip
    Dhoot, Dhiraj
    Sarda, Aarti
    [J]. INDIAN JOURNAL OF DERMATOLOGY, 2020, 65 (05) : 396 - 400
  • [44] Long-term efficacy, safety, and drug survival of secukinumab in patients with psoriasis in Turkey: a retrospective analysis of real-world experience
    Yildirim, Fatma Elif
    Hapa, Fatma Asli
    [J]. POSTEPY DERMATOLOGII I ALERGOLOGII, 2024, 41 (01): : 49 - 55
  • [45] Real-world effectiveness, drug survival and safety of risankizumab over a period of 2 years in 158 patients with moderate-to-severe plaque psoriasis
    Rompoti, Natalia
    Stefanaki, Irene
    Panagakis, Pantelis
    Papoutsaki, Marina
    Politou, Maria
    Vavouli, Charitomeni
    Befon, Angeliki
    Kousta, Fiori
    Lazou, Eleni
    Zaimi, Maria
    Koumprentziotis, Ioannis-Alexios
    Chasapi, Vasiliki
    Rigopoulos, Dimitrios
    Stratigos, Alexander
    Nicolaidou, Electra
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024,
  • [46] Persistence and effectiveness of guselkumab treatment in patients with moderate-to-severe plaque psoriasis in a non-interventional real-world setting: The SPRING study
    Puig, L.
    Dauden, E.
    Cuervas-Mons, M.
    Novella, C.
    Guisado, C.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023,
  • [47] Pharmacoeconomic study of biologics for psoriasis treatment based on real-world drug survival
    Saisyo, Atsuyuki
    Yamaguchi, Michiya
    Kashibe, Koichi
    Ishida, Haku
    Hirano, Yasushi
    Oka, Tomoyuki
    Tamura, Miho
    Takasago, Miwako
    Uchida, Yutaka
    Kouda, Kyoji
    Kitahara, Takashi
    [J]. DERMATOLOGIC THERAPY, 2022, 35 (05)
  • [48] Brodalumab in plaque psoriasis: Real-world data on effectiveness, safety and clinical predictive factors of initial response and drug survival over a period of 104 weeks
    Rompoti, Natalia
    Politou, Maria
    Stefanaki, Irene
    Vavouli, Charitomeni
    Papoutsaki, Marina
    Neofotistou, Afroditi
    Rigopoulos, Dimitrios
    Stratigos, Alexander
    Nicolaidou, Electra
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (04) : 689 - 697
  • [49] Anti-interleukin-23 for psoriasis in elderly patients: guselkumab, risankizumab and tildrakizumab in real-world practice
    Ruggiero, A.
    Fabbrocini, G.
    Cinelli, E.
    Garza, S. S. Ocampo
    Camela, E.
    Megna, M.
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (03) : 561 - 567
  • [50] Real-world drug survival and reasons for treatment discontinuation of biologics and apremilast in patients with psoriasis in an academic center
    Zeb, Lawangeen
    Mhaskar, Rahul
    Lewis, Suzanna
    Patel, Nishit S.
    Sadhwani, Divya
    Patel, Nupur
    Ekhlassi, Erfon
    Lu, Yuanyuan
    Seminario-Vidal, Lucia
    [J]. DERMATOLOGIC THERAPY, 2021, 34 (02)
12345